Current platelet function assays rely on light transmission aggregometry or proprietary cartridge-based systems, which require specialized expertise, dedicated instruments, and expensive consumables ...
BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
Please provide your email address to receive an email when new articles are posted on . An injection of platelet-rich plasma and gonadotropins near the ovarian follicles may help restore ovarian ...
WASHINGTON, DC—Additional evidence, this time from a phase IIb trial in healthy people ages 50 to 80, supports that bentracimab (PhaseBio) provides a near-immediate reversal of ticagrelor’s ...
Next to other complications, cirrhosis is also linked to abnormalities in hemostasis. However, the role of alterations in platelet function had previously been insufficiently investigated. The ...
Use of platelet function testing during dual antiplatelet therapy, including a P2Y12 antagonist, in acute coronary syndromes does not improve clinical outcomes. Researchers at King's College London ...
Managing drug dosage is critical to the overall success of pharmaceutical intervention, not only in the clinic but also in clinical trials. Inadequate dose management of certain drugs can have fatal ...
Ado-trastuzumab emtansine (T-DM1) treatment results in grade 3-4 thrombocytopenia in 8%-13% of patients. Prior in vitro studies reported T-DM1 inhibition of megakaryocyte maturation as the cause of ...
Platelet-rich plasma (PRP) injections into the anterior vaginal wall enhanced sexual function in premenopausal women without severe sexual dysfunction. At 6 months, more than two thirds of women ...
PlateletDiagnostics develops novel immune-based platelet function assay to monitor antiplatelet therapy: Watertown, Massachusetts Wednesday, April 8, 2026, 18:00 Hrs [IST] Platele ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results